Every SEC Form 3/4/5 on record for this filer (CIK 1435183) — 11 issuers, 46 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings, Inc. | Director | 2021-10-05 → 2026-06-05 | 9 | — |
| LH | LABCORP HOLDINGS INC. | Director | 2016-02-11 → 2026-02-13 | 20 | — |
| AONC | American Oncology Network, Inc. | 10% owner · lapsed | 2023-11-09 → 2023-11-09 | 1 | — |
| VERO | Venus Concept Inc. | Director · lapsed | 2019-11-07 → 2023-03-28 | 10 | $2M |
| ALIM | ALIMERA SCIENCES INC | Director · lapsed | 2016-06-27 → 2023-01-06 | 7 | — |
| SBBP | Strongbridge Biopharma plc | Director · lapsed | 2018-01-02 → 2021-10-06 | 9 | — |
| CSTL | CASTLE BIOSCIENCES INC | Filer · lapsed | 2019-07-24 → 2020-05-19 | 10 | −$8M |
| AVDR | AVEDRO INC | Director · lapsed | 2019-02-13 → 2019-11-26 | 4 | $2M |
| HSGX | HISTOGENICS CORP | Director · lapsed | 2016-12-19 → 2018-06-19 | 3 | — |
| MLNT | MELINTA THERAPEUTICS, INC. /NEW/ | Director · lapsed | 2018-06-14 → 2018-06-14 | 1 | — |
| CEMP | CEMPRA, INC. | Director · lapsed | 2015-10-26 → 2017-01-05 | 3 | $49,327 |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
3 of 11 issuers are covered and open a security page; the rest are on file here only.
